Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2025)
Elanco Animal Health (ELAN) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $13.4 billion as the latest value for Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 5.9% to $13.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.6 billion through Dec 2025, changed 0.16% year-over-year, with the annual reading at $13.4 billion for FY2025, 5.9% up from the prior year.
- Liabilities and Shareholders Equity hit $13.4 billion in Q4 2025 for Elanco Animal Health, down from $13.6 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $17.0 billion in Q1 2021 to a low of $12.6 billion in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $14.8 billion across 5 years, with a median of $14.7 billion in 2022.
- Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 74.64% in 2021 and later dropped 12.86% in 2024.
- Year by year, Liabilities and Shareholders Equity stood at $16.5 billion in 2021, then fell by 5.99% to $15.5 billion in 2022, then dropped by 7.29% to $14.4 billion in 2023, then dropped by 12.17% to $12.6 billion in 2024, then rose by 5.9% to $13.4 billion in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for ELAN at $13.4 billion in Q4 2025, $13.6 billion in Q3 2025, and $13.7 billion in Q2 2025.